SYS6055 Injection

SYS6055 · Beijing Kangchuanglian Biopharmaceutical Technology Research Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SYS6055 Injection, covering 2026-03-17 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of SYS6055 Injection in Participants With Relapsed/Refractory Aggressive B-Cell Lymphoma [Phase 1, Phase 2]

See pricing